TY - CONF AU - Valladares Ayerbes, Manuel PY - 2015 SN - 0959-8049 UR - http://hdl.handle.net/20.500.11940/7021 LA - eng TI - Early tumour shrinkage (ETS) and depth of response (DpR) with first-line panitumumab (P) plus FOLFOX4 (P-FOLFOX4) or FOLFIRI (P-FOLFIRI) in patients (pts) with wild-type (WT) RAS colorectal cancer (CRC) and liver-limited disease (LLD) VL - 51 ER -